Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2019

Open Access 01-12-2019 | Neuropathic Pain | Review article

Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options

Authors: Giulia Di Stefano, Stine Maarbjerg, Andrea Truini

Published in: The Journal of Headache and Pain | Issue 1/2019

Login to get access

Abstract

Background

Trigeminal neuralgia is one of the most characteristic and difficult to treat neuropathic pain conditions in patients with multiple sclerosis. The present narrative review addresses the current evidence on diagnostic tests and treatment of trigeminal neuralgia secondary to multiple sclerosis.

Methods

We searched for relevant papers within PubMed, EMBASE and the Cochrane Database of Systematic Reviews, taking into account publications up to December 2018.

Results

Trigeminal neuralgia secondary to multiple sclerosis manifests with facial paroxysmal pain triggered by typical manoeuvres; neurophysiological investigations and MRI support the diagnosis, providing the definite evidence of trigeminal pathway damage. A dedicated MRI is required to identify pontine demyelinating plaques. In many patients with multiple sclerosis, neuroimaging and surgical evidence suggests that neurovascular compression might act in concert with the pontine plaque through a double-crush mechanism. Although no placebo-controlled trials have been conducted in these patients, according to expert opinion the first-line therapy for trigeminal neuralgia secondary to multiple sclerosis relies on sodium-channel blockers, i.e. carbamazepine and oxcarbazepine. The sedative and motor side effects of these drugs frequently warrant an early consideration for neurosurgery. Surgical procedures include Gasserian ganglion percutaneous techniques, gamma knife radiosurgery and microvascular decompression in the posterior fossa.

Conclusions

The relatively poor tolerability of the centrally-acting drugs carbamazepine and oxcarbazepine highlights the need to develop new selective and better-tolerated sodium-channel blockers. Prospective studies based on more advanced neuroimaging techniques should focus on how trigeminal anatomical abnormalities may be able to predict the efficacy of microvascular decompression.
Literature
1.
Solaro C, Trabucco E, Messmer Uccelli M (2013) Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep 13:320PubMedCrossRef
2.
Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211
3.
Cruccu G, Finnerup NB, Jensen TS, Scholz J, Sindou M, Svensson P, Treede RD, Zakrzewska JM, Nurmikko T (2016) Trigeminal neuralgia: new classification and diagnostic grading for practice and research. Neurology 87:220–228PubMedPubMedCentralCrossRef
4.
Maarbjerg S, Gozalov A, Olesen J, Bendtsen L (2014) Trigeminal neuralgia--a prospective systematic study of clinical characteristics in 158 patients. Headache 54:1574–1582PubMedCrossRef
5.
Cruccu G, Biasiotta A, Galeotti F, Iannetti GD, Truini A, Gronseth G (2006) Diagnostic accuracy of trigeminal reflex testing in trigeminal neuralgia. Neurology 10(66):139–141CrossRef
6.
Di Stefano G, Maarbjerg S, Nurmikko T, Truini A, Cruccu G (2018) Triggering trigeminal neuralgia. Cephalalgia 38:1049–1056PubMedCrossRef
7.
Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT (1991) Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945–1984. Neuroepidemiology 10:276–281PubMedCrossRef
8.
9.
Jensen TS, Rasmussen P, Reske-Nielsen E (1982) Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta Neurol Scand 65:182–189PubMedCrossRef
10.
Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D’Aleo G, Gasperini C, Ghezzi A, Martinelli V, Milanese C, Patti F, Trojano M, Verdun E, Mancardi GL, PaIMS Study Group (2004) The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 63:919–921PubMedCrossRef
11.
Martinelli Boneschi F, Colombo B, Annovazzi P, Martinelli V, Bernasconi L, Solaro C, Comi G (2008) Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler 14:514–251PubMedCrossRef
12.
Solaro C, Cella M, Signori A, Martinelli V, Radaelli M, Centonze D, Sica F, Grasso MG, Clemenzi A, Bonavita S, Esposito S, Patti F, D’Amico E CG, Truini A, Neuropathic Pain Special Interest Group of the Italian Neurological Society (2018) Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria. J Neurol 265:828–835PubMedCrossRef
13.
Zakrzewska JM (2013) Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain 25(14):37CrossRef
14.
Devor M, Amir R, Rappaport ZH (2002) Pathophysiology of trigeminal neuralgia: the ignition hypothesis. ClinJPain 18:4–13
15.
Cruccu G, Biasiotta A, Di Rezze S, Fiorelli M, Galeotti F, Innocenti P, Mameli S, Millefiorini E, Truini A (2009) Trigeminal neuralgia and pain related to multiple sclerosis. Pain 143:186–191PubMedCrossRef
16.
Truini A, Prosperini L, Calistri V et al (2016) A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis. Neurology 31(86):2094–2099CrossRef
17.
Nurmikko TJ, Gupta S, Maclver K (2010) Multiple sclerosis-related central pain disorders. Curr Pain Headache Rep 14:189–195PubMedCrossRef
18.
Cruccu G, Gronseth G, Alksne J et al (2008) AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 15:1013–1028PubMedCrossRef
19.
Chen DQ, DeSouza DD, Hayes DJ, Davis KD, O'Connor P, Hodaie M (2016) Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis. Mult Scler 22:51–63PubMedCrossRef
20.
Truini A, Barbanti P, Pozzilli C, Cruccu G (2013 Feb) A mechanism-based classification of pain in multiple sclerosis. J Neurol 260(2):351–367PubMedCrossRef
21.
22.
Broggi G, Ferroli P, Franzini A et al (2004) Operative findings and outcomes of microvascular decompression for trigeminal neuralgia in 35 patients affected by multiple sclerosis. Neurosurgery 55:830–838PubMedCrossRef
23.
24.
Burchiel KJ (1980) Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg 53:674–683PubMedCrossRef
25.
Devor M, Govrin-Lippmann R, Rappaport ZH (2002) Mechanism of trigeminal neuralgia: an ultrastructural analysis of trigeminal root specimens obtained during microvascular decompression surgery. J Neurosurg 96:532–543PubMedCrossRef
26.
Truini A, Garcia-Larrea L, Cruccu G (2013) Reappraising neuropathic pain in humans--how symptoms help disclose mechanisms. Nat Rev Neurol 9:572–582PubMedCrossRef
27.
Obermann M, Yoon MS, Ese D et al (2007) Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 28(69):835–841CrossRef
28.
Leandri M, Eldridge P, Miles J (1998) Recovery of nerve conduction following microvascular decompression for trigeminal neuralgia. Neurology 51:1641–1646PubMedCrossRef
29.
Cruccu G, Deuschl G (2000) The clinical use of brainstem reflexes and hand-muscle reflexes. Clin Neurophysiol 111:371–387PubMedCrossRef
30.
Swinnen C, Lunskens S, Deryck O, Casselman J, Vanopdenbosch L (2013) MRI characteristics of trigeminal nerve involvement in patients with multiple sclerosis. Mult Scler Relat Disord 2:200–203PubMedCrossRef
31.
Antonini G, Di Pasquale A, Cruccu G et al (2014) Magnetic resonance imaging contribution for diagnosing symptomatic neurovascular contact in classical trigeminal neuralgia: a blinded case-control study and meta-analysis. Pain 155:1464–1471PubMedCrossRef
32.
Ramsaransing G, Zwanikken C, De Keyser J (2000) Worsening of symptoms of multiple sclerosis associated with carbamazepine. BMJ 22:320–1113
33.
Leandri M, Lundardi G, Inglese M et al (2000) Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol 247:556–558PubMedCrossRef
34.
Solaro C, Lunardi GL, Capello E et al (1998) An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 51:609–611PubMedCrossRef
35.
Solaro C, Boehmker M, Tanganelli P (2009) Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study. J Neurol 256:1773–1774PubMedCrossRef
36.
D’Aleo G, Sessa E, Di Bella P, Rifici C, Restivo DA, Bramanti P (2001) Topiramate modulation of R3 nociceptive reflex in multiple sclerosis patients suffering paroxysmal symptoms. J Neurol 248:996–999PubMedCrossRef
37.
Reder AT, Arnason BG (1995) Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology 45:1097–1100PubMedCrossRef
38.
Solaro C, Messmer Uccelli M, Uccelli A, Leandri M, Mancardi GL (2000) Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol 44:45–48PubMedCrossRef
39.
Espir MLE, Millac P (1970) Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (tegretol). J Neurol Neurosurg Psychiatry 33:528–531PubMedPubMedCentralCrossRef
40.
Lunardi G, Leandri M, Albano C, Cultrera S, Fracassi M, Rubino V et al (1997) Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48:1714–1717PubMedCrossRef
41.
Khan OA (1998) Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 51:611–614PubMedCrossRef
42.
Zvartau-Hind M, Din MU, Gilani A, Lisak RP, Khan OA (2000) Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 55:1587–1588PubMedCrossRef
43.
Solaro CM, Ferriero G (2018) Refactory trigeminal neuralgia successfully treated by combination therapy (Pregabalin plus lamotrigine). Mult Scler Relat Disord 25:165–166PubMedCrossRef
44.
Pfau G, Brinkers M, Treuheit T, Kretzschmar M, Sentürk M, Hachenberg T (2012) Misoprostol as a therapeutic option for trigeminal neuralgia in patients with multiple sclerosis. Pain Med 13:1377–1378PubMedCrossRef
45.
DMKG study group (2003) Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J Neurol 250:542–525CrossRef
46.
Pöllmann W, Feneberg W (2008) Current management of pain associated with multiple sclerosis. CNS Drugs 22:291–324PubMedCrossRef
47.
Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T, European Federation of Neurological Societies (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:1113–1e88PubMedCrossRef
48.
Campbell FG, Graham JG, Zilkha KJ (1966) Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 29:265–267PubMedPubMedCentralCrossRef
49.
Rockcliff BW, Davis EH (1966) Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 15:129–136CrossRef
50.
51.
Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A (2005) Anticonvulsant drugs for acute and chronic pain Cochrane Database Syst Rev CD001133
52.
Wiffen PJ, Derry S, Moore RA, McQuay HJ (2011) Carbamazepine for acute and chronic pain in adults. In: Cochrane database Syst rev 19;(1):CD005451
53.
Di Stefano G, La Cesa S, Truini A, Cruccu G (2014) Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary Centre for neuropathic pain. J Headache Pain 9(15):34CrossRef
54.
Liebel JT, Menger N, Langohr H (2001) Oxcarbazepine in der Behandlung der Trigeminusneuralgie. Nervenheilkunde 20:461–465
55.
Beydoun A (2000) Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy 20:152S–158SPubMedCrossRef
56.
Solaro C, Uccelli MM (2011) Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol 7:519–527PubMedCrossRef
57.
Di Stefano G, Truini A (2017) Pharmacological treatment of trigeminal neuralgia. Expert Rev Neurother 17:1003–1011PubMedCrossRef
58.
Zakrzewska JM, Palmer J, Morisset V, Giblin GM, Obermann M, Ettlin DA, Cruccu G, Bendtsen L, Estacion M, Derjean D, Waxman SG, Layton G, Gunn K, Tate S, investigators s (2017) Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol 16:291–300PubMedCrossRef
59.
Mohammad-Mohammadi A, Recinos PF, Lee JH, Elson P, Barnett GH (2013) Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis. Neurosurgery 73:941–950PubMedCrossRef
60.
Zakrzewska JM, Wu J, S-L Brathwaite T (2017) A systematic review of the management of trigeminal neuralgia in patients with multiple sclerosis. World Neurosurg pii S1878-8750(17):32263–32265
61.
Pickett GE, Bisnaire D, Ferguson GG (2005) Percutaneous retrogasserian glycerol rhizotomy in the treatment of tic douloureux associated with multiple sclerosis. Neurosurgery 56:537–545PubMedCrossRef
62.
Mallory GW, Atkinson JL, Stien KJ, Keegan BM, Pollock BE (2012) Outcomes after percutaneous surgery for patients with multiple sclerosis-related trigeminal neuralgia. Neurosurgery 71:581–586PubMedCrossRef
63.
Krishnan S, Bigder M, Kaufmann AM (2018 Jan) Long-term follow-up of multimodality treatment for multiple sclerosis-related trigeminal neuralgia. Acta Neurochir 160(1):135–144PubMedCrossRef
64.
Berk C, Constantoyannis C, Honey CR (2003) The treatment of trigeminal neuralgia in patients with multiple sclerosis using percutaneous radiofrequency rhizotomy. Can J Neurol Sci 30:220–223PubMedCrossRef
65.
Rogers CL, Shetter AG, Ponce FA, Fiedler JA, Smith KA, Speiser BL (2002) Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis. J Neurosurg 97:529–532PubMedCrossRef
66.
Broggi G, Ferroli P, Franzini A, Pluderi M, La Mantia L, Milanese C (1999) Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis. Lancet 27(354):1878–1879CrossRef
67.
Leandri M (2003) Therapy of trigeminal neuralgia secondary to multiple sclerosis. Expert Rev Neurother 3:661–671PubMedCrossRef
68.
Montano N, Papacci F, Cioni B, Di Bonaventura R, Meglio M (2013) What is the best treatment of drug-resistant trigeminal neuralgia in patients affected by multiple sclerosis? A literature analysis of surgical procedures. Clin Neurol Neurosurg 115:567–572PubMedCrossRef
69.
Cruccu G (2017) Trigeminal Neuralgia. Continuum (Minneap Minn) 23:396–420
70.
Mathieu D, Effendi K, Blanchard J, Séguin M (2012) Comparative study of gamma knife surgery and percutaneous retrogasserian glycerol rhizotomy for trigeminal neuralgia in patients with multiple sclerosis. J Neurosurg 117(Suppl):175–180PubMedCrossRef
71.
Dieckmann G, Veras G, Sogabe K (1987) Retrogasserian glycerol injection or percutaneous stimulation in the treatment of typical and atypical trigeminal pain. Neurol Res 9:48–49PubMedCrossRef
72.
Kondziolka D, Lunsford LD, Bissonette DJ (1994) Long-term results after glycerol rhizotomy for multiple sclerosis-related trigeminal neuralgia. Can J Neurol Sci 21:137–140PubMedCrossRef
73.
Kouzounias K, Schechtmann G, Lind G, Winter J, Linderoth B (2010) Factors that influence outcome of percutaneous balloon compression in the treatment of trigeminal neuralgia. Neurosurgery 67:925–934PubMedCrossRef
74.
Montano N, Papacci F, Cioni B, Di Bonaventura R, Meglio M (2012) Percutaneous balloon compression for the treatment of trigeminal neuralgia in patients with multiple sclerosis. Analysis of the potentially prognostic factors. Acta Neurochir 154:779–783PubMedCrossRef
75.
Bergenheim AT, Asplund P, Linderoth B (2013) Percutaneous retrogasserian balloon compression for trigeminal neuralgia: review of critical technical details and outcomes. World Neurosurg 79:359–368PubMedCrossRef
76.
Martin S, Teo M, Suttner N (2015) The effectiveness of percutaneous balloon compression in the treatment of trigeminal neuralgia in patients with multiple sclerosis. J Neurosurg 123:1507–1511PubMedCrossRef
77.
Broggi G, Franzini A (1982) Radiofrequency trigeminal rhizotomy in treatment of symptomatic non-neoplastic facial pain. J Neurosurg 57:483–486PubMedCrossRef
78.
Kanpolat Y, Berk C, Savas A, Bekar A (2000) Percutaneous controlled radiofrequency rhizotomy in the management of patients with trigeminal neuralgia due to multiple sclerosis. Acta Neurochir 142:685–689 discussion 689-690PubMedCrossRef
79.
Tyurnikov VM, Peresedova AV, Gushcha AO, Koval' KV (2015) Experience in the use of high-frequency selective percutaneous rhizotomy in trigeminal neuralgia associated with multiple sclerosis. Zh Vopr Neirokhir Im N N Burdenko 79:34–41PubMedCrossRef
80.
Huang E, Teh BS, Zeck O, Woo SY, Lu HH, Chiu JK, Butler EB, Gormley WB, Carpenter LS (2002) Gamma knife radiosurgery for treatment of trigeminal neuralgia in multiple sclerosis patients. Stereotact Funct Neurosurg 79:44–50PubMedCrossRef
81.
Weller M, Marshall K, Lovato JF, Bourland JD, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Chan MD (2014) Single-institution retrospective series of gamma knife radiosurgery in the treatment of multiple sclerosis-related trigeminal neuralgia: factors that predict efficacy. Stereotact Funct Neurosurg 92:53–58PubMedCrossRef
82.
Zorro O, Lobato-Polo J, Kano H, Flickinger JC, Lunsford LD, Kondziolka D (2009) Gamma knife radiosurgery for multiple sclerosis-related trigeminal neuralgia. Neurology 73:1149–1154PubMedCrossRef
83.
Conti A, Pontoriero A, Iatì G, Esposito F, Siniscalchi EN, Crimi S, Vinci S, Brogna A, De Ponte F, Germanò A, Pergolizzi S, Tomasello F (2017) Frameless stereotactic radiosurgery for treatment of multiple sclerosis-related trigeminal neuralgia. World Neurosurg 103:702–712PubMedCrossRef
84.
Tuleasca C, Carron R, Resseguier N, Donnet A, Roussel P, Gaudart J, Levivier M, Régis J (2014) Multiple sclerosis-related trigeminal neuralgia: a prospective series of 43 patients treated with gamma knife surgery with more than one year of follow-up. Stereotact Funct Neurosurg 92:203–210PubMedCrossRef
85.
Przybylowski CJ, Cole TS, Baranoski JF, Little AS, Smith KA, Shetter AG (2018) Radiosurgery for multiple sclerosis-related trigeminal neuralgia: retrospective review of long-term outcomes. J Neurosurg 1:1–8
86.
Alvarez-Pinzon AM, Wolf AL, Swedberg HN, Barkley KA, Cucalon J, Curia L, Valerio JE (2017) Comparison of percutaneous Retrograsserian balloon compression and gamma knife radiosurgery for the treatment of trigeminal neuralgia in multiple sclerosis. World Neurosurg 97:590–594PubMedCrossRef
87.
Holland MT, Teferi N, Noeller J, Swenson A, Smith M, Buatti J, Hitchon PW (2017) Stereotactic radio surgery and radio frequency rhizotomy for trigeminal neuralgia in multiple sclerosis: a single institution experience. Clin Neurol Neurosurg 162:80–84PubMedCrossRef
88.
Athanasiou TC, Patel NK, Renowden SA, Coakham HB (2005) Some patients with multiple sclerosis have neurovascular compression causing their trigeminal neuralgia and can be treated effectively with MVD: report of five cases. Br J Neurosurg 19:463–468PubMedCrossRef
89.
Eldridge PR, Sinha AK, Javadpour M, Littlechild P, Varma TR (2003) Microvascular decompression for trigeminal neuralgia in patients with multiple sclerosis. Stereotact Funct Neurosurg 81:57–64PubMedCrossRef
90.
Sandell T, Eide PK (2010) The effect of microvascular decompression in patients with multiple sclerosis and trigeminal neuralgia. Neurosurgery 67:749–753PubMedCrossRef
91.
Ariai MS, Mallory GW, Pollock BE (2014) Outcomes after microvascular decompression for patients with trigeminal neuralgia and suspected multiple sclerosis. World Neurosurg 81:599–603PubMedCrossRef
92.
Barker FG 2nd, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD (1996) The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 25(334):1077–1083CrossRef
Metadata
Title
Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options
Authors
Giulia Di Stefano
Stine Maarbjerg
Andrea Truini
Publication date
01-12-2019
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 1/2019
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/s10194-019-0969-0

Other articles of this Issue 1/2019

The Journal of Headache and Pain 1/2019 Go to the issue

Research Article

Identifying menstrual migraine– improving the diagnostic criteria using a statistical method

Review article

The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis

Research article

C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system

Research article

Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care

Research article

Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine

Research article

Late sodium current blocker GS967 inhibits persistent currents induced by familial hemiplegic migraine type 3 mutations of the SCN1A gene